著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Jacobus Pfisterer and Florence Joly and Gunnar Kristensen and Joern Rau and Sven Mahner and Patricia Pautier and Ahmed El-Balat and Jean-Emmanuel Kurtz and Ulrich Canzler and Jalid Sehouli and Martin L. Heubner and Andreas D. Hartkopf and Klaus Baumann and Annette Hasenburg and Lars C. Hanker and Antje Belau and Barbara Schmalfeldt and Dominik Denschlag and Tjoung-Won Park-Simon and Frédéric Selle and Christian Jackisch and Alexander Burges and Hans-Joachim Lück and Günter Emons and Werner Meier and Martina Gropp-Meier and Willibald Schröder and Nikolaus de Gregorio and Felix Hilpert and Philipp Harter,Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial,Journal of Clinical Oncology,0732-183X,American Society of Clinical Oncology (ASCO),2023-02-01,41,4,893-902,https://cir.nii.ac.jp/crid/1360302870448694912,https://doi.org/10.1200/jco.22.01010